Newsletter Archive
-
05.23.23 -- 5 Characteristics Of The Automated Microbiology Lab Of The Future
5/23/2023
05/23/23 Laboratory Network Newsletter
-
05.09.23 -- Protecting Cell And Gene Therapy R&D Against Cyber Threats
5/9/2023
05/09/23 Laboratory Network Newsletter
-
04.25.23 -- Increase In FDA Inspections + Whistleblower Complaints = Heightened Compliance Scrutiny
4/25/2023
04/25/23 Laboratory Network Newsletter
-
04.11.23 -- ICH Guideline Q9(R1) On QRM, Part 1: Formality & Risk-based Decisions
4/11/2023
04/11/23 Laboratory Network Newsletter
-
03.28.23 -- Trends In FDA FY2022 Inspection-based Warning Letters
3/28/2023
03/28/23 Laboratory Network Newsletter
-
03.14.23 -- Considerations For Microbial Enumeration Methods When Working With CDMOs
3/14/2023
03/14/23 Laboratory Network Newsletter
-
02.28.23 -- FDA Adopts ICH Final Guidance On Bioanalytical Method Validation
2/28/2023
02/28/23 Laboratory Network Newsletter
-
02.14.23 -- Considerations For Sterility Test Methods When Working With CDMOs
2/14/2023
02/14/23 Laboratory Network Newsletter
-
01.24.23 -- FDA Seeks Comment On Circumstances For Delaying, Denying, Limiting, Or Refusing An Inspection
1/24/2023
01/24/23 Laboratory Network Newsletter
-
01.10.23 -- ICH Issues Draft Guideline On Viral Safety Evaluation Of Biotech Products
1/10/2023
01/10/23 Laboratory Network Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more